Sterling Medical Devices & RBC Medical Innovations are combining to create Vantage MedTech! Meet RBC
Contact Us
Close Form

Interested in learning more about how we can work together in your current or next medical device design project?

Just fill out this form and we’ll be in touch!

  • This field is for validation purposes and should be left unchanged.

Wherever you are in your product development lifecycle,
Sterling can help.

P: 201-877-5682
F: 201-301-9169

FDA Medical Device User Fees (MDUFA) for 2024

Author: Carrie Britton | Date: August 22, 2023

Professional calculating medical device finances.

On July 28, 2023, the Food and Drug Administration (FDA) announced the fee rates and payment procedures for medical device user fees for fiscal year (FY) 2024.[1] The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Medical Device User Fee Amendments of 2022 (MDUFA V), authorizes the FDA to collect medical device user fees for certain device submissions and annual fees, both for certain periodic reports and for establishments subject to registration. This notice establishes the fee rates for FY 2024, which apply from October 1, 2023, through September 30, 2024—and provides information on how the medical device user fee rates for fiscal year 2024 were determined, the payment procedures you should follow, and how you may qualify for reduced small business fees.

Medical device firms are required to pay fees to the FDA under the user fee system when they register their businesses and list their products with the agency, when they apply or notification [SY1] to sell a new medical device in the United States, and for a few other types of submissions. With the aim of speeding up the process of bringing safe and effective medical devices to the U.S. market, these fees assist the FDA in improving the effectiveness of regulatory procedures.

All establishments must pay an FDA annual registration fee; there are no waivers or reductions for small establishments, businesses, or groups in the FY 2024. However, the FDA registration fee for the first Premarket Approval Application (PMA), Product Development Protocol (PDP), Premarket Report (PMR), or Biologics License Application (BLA) is waived for small businesses with an approved Small Business Determination (SBD) whose gross receipts or sales are $30 million or less. And small businesses with approved Small Business Determination (SBD) and gross receipts or sales of $100 million or less may be eligible for reduced medical device user fees for Premarket Notification (510(k)), De Novo request, Premarket Applications (Premarket Approval Application (PMA)), Biologics License Application (BLA), Product Development Protocol (PDP), Premarket Report (PMR), PMA/BLA Supplements and PMA Annual Reports, and 513(g) request for classification information.

The FDA User Fees for 2024 vs. 2023 at a Glance

The difference between FDA medical device user fees from 2023 and 2024 are summarized in the table below:

Application TypeMDUFA Fees FY 2023MDUFA Fees FY 2024
Standard FeeSmall Business FeeStandard FeeSmall Business Fee
PMA, PDP, PMR, BLA$441,547$110,387$483,560$120,890
De Novo Classification Request$132,464$33,116$145,068$36,267
Panel-track Supplement$353,238$88,309$386,848$96,712
180-Day Supplement$66,232$16,558$72,534$18,134
Real-Time Supplement$30,908$7,727$33,849$8,462
BLA Efficacy Supplement$441,547$110,387$483,560$120,890
30-Day Notice$7,065$3,532$7,737$3,869
Annual Fee for Periodic Reporting on a Class III device (PMAs, PDPs, and PMRs)$15,454$3,864$16,925$4,231

For more information about the MDUFA decision, the new MDUFA user fees for 2024, or to learn more about how to get FDA approval for your medical device, contact us here.

[1] Federal Register :: Medical Device User Fee Rates for Fiscal Year 2024

Share this!

Contact Us

  • This field is for validation purposes and should be left unchanged.


Physician working on tablet in hospital room

March 15, 2022

Recent Advances in Medical Technology

The impact of the COVID-19 global pandemic will be evaluated, studied, and felt for years to come, especially in the medical device industry. To protect public health, health care providers...
Read More >
View More Blogs

February 18, 2021

5 Mistakes Medical Device Startups Make

Startups are the lifeblood of medical device innovation. Without universities researching ways to solve pressing healthcare problems or doctors with experience in a particular field who have an idea to develop a prototype medical device that could help patients, the future technologies needed to help save lives wouldn't happen. But the long, arduous road through the FDA submission process to get market approval can take a long time and cost a lot of money without help. Sterling Medical Devices has been helping startups through the FDA approval process since 1998 without ever having a submission rejected.
Read More >
View More Videos
active drug delivery system

September 8, 2020

Implanted Drug Delivery System

Sterling Medical Devices designed and developed a Class III pain medication delivery system for patients with spinal injuries. The system is comprised of three devices: an implantable pump, a handheld Clinician Programmer, and a handheld Patient Therapy Controller. The pump is surgically implanted into the patient, and the two handheld devices each communicate with the pump when held within close proximity of it....
Read More >
View More Case Studies

Need help with your medical device?

Let Sterling Medical Devices show how to bring your idea from concept to prototype to
FDA/CE approval with a free custom project analysis.
Request Free Analysis